Sentinel Diagnostics’ Post

🔬 Exciting Advances in #AptamerResearch & #LateralFlowAssays for Early Disease Diagnosis! 🌟 Traditional antibody-based detection methods have long been the gold standard, but #Aptamers are changing the game. Aptamers are single-stranded DNA/RNA molecules that bind specifically to target molecules, offering several advantages over antibodies. 🧬 Precision: Aptamers are tailored for high specificity, reducing false positives. 🚀 Speed: Lateral flow assays using aptamers provide rapid results, crucial in early diagnosis. 🌱 Customization: Aptamers can be easily synthesized for various targets, enhancing versatility. 💼 Cost-Efficiency: Aptamer production is cost-effective and scalable. This innovation empowers early disease detection, revolutionizing healthcare. Let's continue to explore the potential of aptamers in diagnostics and pave the way for a healthier future! 🏥💪 #MedicalResearch #HealthcareInnovation #DiseaseDiagnosis #ScienceAdvancements

Check out another insight from our recent EUROIMMUN Academy Webinar, where we discussed the intricate world of IFA-ANA diagnostics alongside esteemed guest speaker Dr. Anne Tebo, PhD, from Mayo Clinic. Watch the whole webinar on our YouTube channel and be sure to subscribe! http://ms.spr.ly/6042cEYpA #ANATesting #Diagnostics #ANAWebinar #IFATesting

Watch this video, where Prof. Sylvain Lehmann shares insights on the impact of biomarker diagnostics in #AlzheimersDisease and why a timely diagnosis is vital.¹⁻³ #ADPD24. For Healthcare professionals.

Explore the Future of Drug Discovery with MIMETAS! Dive into our latest video, featuring insights from Jos Joore, our CEO, as he discusses the power of human 3D disease models. At MIMETAS, we provide an innovative approach, enabling you to test compounds in advanced disease models for more accurate clinical predictions. Embark on a phenotypic discovery journey with us as we deliver human-relevant models today to unlock groundbreaking therapies of tomorrow. Learn more here: https://lnkd.in/e5sEz8Mj #DrugDiscovery #PhenotypicScreening #DrugDevelopment

Exciting times in healthcare! Genomics and personalized medicine are transforming the landscape by tailoring treatments to individual DNA. This innovative approach allows for targeted therapies, early disease detection, and optimized drug prescriptions, promising a future of more precise and effective medical care. Let's embrace this revolution and work towards a future where healthcare is truly personalized. #Genomics #PersonalizedMedicine #HealthcareInnovation #PrecisionMedicine #myEZcare

Integrate biomarker data early to advance bispecifics to the clinic, faster. Learn more by attending our talk with Raffi Tonikian at the World Bispecific Summit. #antibodytherapeutics #antibodydiscovery #bispecifics

Exciting times in healthcare! Genomics and personalized medicine are transforming the landscape by tailoring treatments to individual DNA. This innovative approach allows for targeted therapies, early disease detection, and optimized drug prescriptions, promising a future of more precise and effective medical care. Let's embrace this revolution and work towards a future where healthcare is truly personalized. #Genomics #PersonalizedMedicine #HealthcareInnovation #PrecisionMedicine #myEZcare

🔬 LIVe2024 RECAP: The Lung In Vitro Event 🫁 ✨️ A resounding success!   The LIVe2024 congress, organized by Epithelix and ALTERTOX in Nice, France (June 20-21), brought together scientists, industry leaders and regulatory experts interested in advancing in vitro respiratory research.    ✨ Cutting-edge models, real-world impact!  The focus was on the latest developments in in vitro lung models, with applications from basic research to drug discovery, efficacy testing and toxicity assessment.    ✨ Collaboration for a healthier future!  LIVe2024 fostered lively discussions on how these innovative models can accelerate progress in lung disease treatment.     Let us know in the comments what you found most interesting about the #LIVe2024 Congress!     #LIVe2024 #Invitro #Lungresearch #NAMs #Congress 

Sun. Sand. Blood-based screening. How can anyone resist? I’ll be speaking at the 2024 Precision Med TRI-CON in San Diego, March 26-28th. https://shorturl.at/kmtK8 Let me know if you’ll be going and would like either a local’s guide to the best tacos or to catch up and talk all things #earlydetection and #diagnostics. (Only kidding about the sun, it’ll be our version of cold in March…60 degrees). #health #screening #precisionmedicine

Labcorp is ramping up its offerings with the launch of a new, Alzheimer’s disease-specific test. The amyloid-tau-neurodegeneration (ATN) profile tests for three separate biomarkers associated with Alzheimer’s disease. Though it’s not meant to make a definitive diagnosis, the test’s results can help doctors evaluate whether a patient with cognitive impairment is also experiencing any of the biological changes linked to Alzheimer’s—therefore potentially speeding up the time it takes to order further testing, reach a diagnosis and begin treatment for the disease. Smarteeva keeps you a step ahead with the latest news on the medical device industry. Follow us on social media. Learn more about us-https://lnkd.in/g9BGGbrK #labcorp #smarteeva #biotech #medtech #postmarketsurveillance #fda